Effects of neuropeptide S on seizures and oxidative damage induced by pentylenetetrazole in mice

Pharmacology Biochemistry and Behavior

Volumn 103, Issue 2, 2012, Pages 197-203

  Ramos, Saulo Fábio ^a   Mendonça, Bruna Pescador ^a   Leffa, Daniela Dimer ^a   Pacheco, Robson ^a   Damiani, Adriani Paganini ^a   Hainzenreder, Giana ^a   Petronilho, Fabrícia ^a   Dal Pizzol, Felipe ^a   Guerrini, Remo ^b   Calo', Girolamo ^b   Gavioli, Elaine Cristina ^c   Boeck, Carina Rodrigues ^a   De Andrade, Vanessa Moraes ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b UNIVERSITY OF FERRARA   (Italy)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

DNA damage; Neuropeptide S; Oxidative stress; Pentylenetetrazole; Seizure

Indexed keywords

DNA; LIPID; NEUROPEPTIDE S; PENTETRAZOLE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CHEMICAL ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; DNA DAMAGE; HIPPOCAMPUS; MACROMOLECULE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SEIZURE;

ANIMALS; BEHAVIOR, ANIMAL; LIPID PEROXIDATION; MALE; MICE; NEUROPEPTIDES; OXIDATIVE STRESS; PENTYLENETETRAZOLE; SEIZURES;

MUS; RODENTIA;

EID: 84866301565     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.09.001     Document Type: Article

References (70)

1. S.H. Akbas, A. Yegin, and T. O' Zben Effect of pentylenetetrazole-induced epileptic seizure on the antioxidant enzyme activities, glutathione and lipid peroxidation levels in rat erythrocytes and liver tissues Clin Biochem 38 2005 1009 1014
2. T. Arora, A.K. Mehta, K.K. Sharma, P.K. Mediratta, B.D. Banerjee, G.R. Garg, and A.K. Sharma Effect of carbamazepine and lamotrigine on cognitive function and oxidative stress in brain during chemical epileptogenesis in rats Basic Clin Pharmacol Toxicol 106 2010 372 377
3. D.O. Barros, S.M. Xavier, C.O. Barbosa, R.F. Silva, R.L. Freitas, F.D. Maia, A.A. Oliveira, R.M. Freitas, and R.N. Takahashi Effects of the vitamin E in catalase activities in hippocampus after status epilepticus induced by pilocarpine in Wistar rats Neurosci Lett 416 2007 227 230
4. B. Beck, B. Fernette, and A. Stricker-Krongrad Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats Biochem Biophys Res Commun 332 2005 859 865
5. M.I. Bellissimo, D. Amado, D.S. Abdalla, E.C. Ferreira, E.A. Cavalheiro, and M.G. Naffah-Mazzacoratti Superoxide dismutase, glutathione peroxidase activities and the hydroperoxide concentration are modified in the hippocampus of epileptic rats Epilepsy Res 46 2001 121 128
6. 2A receptor counteracts neuropeptide-S-induced hyperlocomotion in mice Naunyn Schmiedebergs Arch Pharmacol 381 2010 153 160
7. N. Cannella, D. Economidou, M. Kallupi, S. Stopponi, M. Heilig, M. Massi, and R. Ciccocioppo Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system Neuropsychopharmacology 34 2009 2125 2134
8. J. Cao, L. de Lecea, and S. Ikemoto Intraventricular administration of neuropeptide S has reward-like effects Eur J Pharmacol 658 2011 16 21
9. A.A. Castro, M. Moretti, T.S. Casagrande, C. Martinello, F. Petronilho, A.V. Steckert, R. Guerrini, G. Calo, F. Dal Pizzol, J. Quevedo, and E.C. Gavioli Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: a comparative study with amphetamine and diazepam Pharmacol Biochem Behav 91 2009 636 642
10. A.A. Castro, T.S. Casagrande, M. Moretti, L. Constantino, F. Petronilho, G.C. Guerra, G. Calo', R. Guerrini, F. Dal-Pizzol, J. Quevedo, and E.C. Gavioli Lithium attenuates behavioral and biochemical effects of neuropeptide S in mice Peptides 30 2009 1914 1920
11. B.H. Choi Oxygen, antioxidants and brain dysfunction Yonsei Med J 34 1993 1 10
12. A. Collins, M. Dusinská, M. Franklin, M. Somorovská, H. Petrovská, S. Duthie, L. Fillion, M. Panayiotidis, K. Raslová, and N. Vaughan Comet assay in human biomonitoring studies: reliability, validation, and applications Environ Mol Mutagen 30 1997 139 146
13. C.M. Cremer, N. Palomero-Gallagher, H.J. Bidmon, A. Schleicher, E.J. Speckmann, and K. Zilles Pentylenetetrazole-induced seizures affect binding site densities for GABA, glutamate and adenosine receptors in the rat brain Neuroscience 163 1 2009 490 499
14. L.F. Da Silva, P. Pereira, and E. Elisabetsky A neuropharmacological analysis of PTZ-induced kindling in mice Gen Pharmacol 31 1998 47 50
15. P.A. De Oliveira, F.L. Lino, S.E. Cappelari, B.L.F. da Silva, J.N. Picada, and P. Pereira Effects of gamma-decanolactone on seizures induced by PTZ-kindling in mice Exp Brain Res 187 2008 161 166
16. M. El Yacoubi, C. Ledent, M. Parmentier, J. Costentin, and J.M. Vaugeois Adenosine A2A receptor deficient mice are partially resistant to limbic seizures Naunyn Schmiedebergs Arch Pharmacol 380 2009 223 232
17. M. El Yacoubi, C. Ledent, M. Parmentier, J. Costentin, and J.M. Vaugeois Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine Neuropharmacology 55 1 2008 35 40
18. V. Erakovic, G. Zupan, J. Varljen, and A. Simonic Pentylenetetrazol- induced seizures and kindling: changes in free fatty acids, superoxide dismutase, and glutathione peroxidase activity Neurochem Int 42 2003 173 178
19. H. Esterbauer, and K.H. Cheeseman Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal Methods Enzymol 186 1990 407 421
20. A. Fedeli, S. Braconi, D. Economidou, N. Cannella, M. Kallupi, R. Guerrini, G. Calò, C. Cifani, M. Massi, and R. Ciccocioppo The paraventricular nucleus of the hypothalamus is a neuroanatomical substrate for the inhibition of palatable food intake by neuropeptide S Eur J Neurosci 30 2009 1594 1602
21. J. Folbergrová, and W.S. Kunz Mitochondrial dysfunction in epilepsy Mitochondrion 12 1 2012 35 40
22. R.M. Freitas, S.M. Vasconcelos, F.C. Souza, G.S. Viana, and M.M. Fonteles Oxidative stress in the hippocampus after pilocarpine-induced status epilepticus in Wistar rats FEBS J 272 2005 307 312
23. R.M. Freitas Investigation of oxidative stress involvement in hippocampus in epilepsy model induced by pilocarpine Neurosci Lett 462 2009 225 229
24. D.C. Guzman, I.E. Vázquez, G.B. Mejía, E.H. García, D.S. del Angel, and H.J. Olguín Effect of pentylenetetrazole and carbodiimide on oxidation stress markers in rat brain Basic Clin Pharmacol Toxicol 96 2005 512 513
25. R.W. Han, X.Q. Yin, M. Chang, Y.L. Peng, W. Li, and R. Wang Neuropeptide S facilitates spatial memory and mitigates spatial memory impairment induced by N-methyl-d-aspartate receptor antagonist in mice Neurosci Lett 455 2009 74 77
26. T. Hokfelt, C. Broberger, Z.Q. Xu, V. Sergeyev, R. Ubink, and M. Diez Neuropeptides - an overview Neuropharmacology 39 2000 1337 1356
27. A. Ilhan, A. Gure, F. Armutcu, S. Kamisli, and M. Iraz Antiepileptogenic and antioxidant effects of Nigella sativa oil against pentylenetetrazol-induced kindling in mice Neuropharmacology 49 2005 456 464
28. A. Ilhan, M. Iraz, A. Gurel, F. Armutec, and O. Akyol Caffeic acid phenethyl ester exerts a neuroprotective effect on CNS against pentylenetetrazol-induced seizures in mice Neurochem Res 29 2004 2287 2292
29. P.J. Jensen, N. Millan, and K.J. Mack Cortical NMDAR-1 gene expression is rapidly upregulated after seizure Brain Res Mol Brain Res 44 1997 157 162
30. K. Jüngling, T. Seidenbecher, L. Sosulina, J. Lesting, S. Sangha, S.D. Clark, N. Okamura, D.M. Duangdao, Y.L. Xu, R.K. Reinscheid, and H.C. Pape Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdale Neuron 59 2008 298 310
31. P. Kwan, and M.J. Brodie Emerging drugs for epilepsy Expert Opin Emerg Drugs 12 2007 407 422
32. R. Lage, C. Dieguez, and M. Lopez Caffeine treatment regulates neuropeptide S system expression in the brain Neurosci Lett 410 2006 47 51
33. S.E. Laursen, and J.K. Belknap Intracerebroventricular injections in mice. Some methodological refinements J Pharmacol Methods 16 1986 355 357
34. S.K. Leonard, J.M. Dwyer, S.J. Sukoff Rizzo, B. Platt, S.F. Logue, S.J. Neal, J.E. Malberg, C.E. Beyer, L.E. Schechter, S. Rosenzweig-Lipson, and R.H. Ring Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders Psychopharmacology 197 2008 601 611
35. R.L. Levine, J.A. Williams, E.R. Stadtman, and E. Shacter Carbonyl assays for determination oxidatively modified proteins Methods Enzymol 233 1994 346 357
36. W. Li, M. Chang, Y.L. Peng, Y.H. Gao, J.N. Zhang, R.W. Han, and R. Wang Neuropeptide S produces antinociceptive effects at the supraspinal level in mice Regul Pept 156 2009 90 95
37. Z. Li, Y. Yamamoto, T. Morimoto, J. Ono, S. Okada, and A. Yamatodani The effect of pentylenetetrazole-kindling on the extracellular glutamate and taurine levels in the frontal cortex of rats Neurosci Lett 282 2000 117 119
38. W. Löscher Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy Epilepsy Res 50 2002 105 123
39. J.C. McHugh, and N. Delanty Epidemiology and classification of epilepsy: gender comparisons Int Rev Neurobiol 83 2008 11 26
40. T. Mochizuki, J. Kim, and K. Sasaki Microinjection of neuropeptide S into the rat ventral tegmental area induces hyperactivity and increases extracellular levels of dopamine metabolites in the nucleus accumbens shell Peptides 31 2010 926 931
41. S.B. Nadin, L.M. Vargas-Roig, and D.R. Ciocca A silver staining method for single-cell gel assay J Histochem Cytochem 49 2001 1183 1186
42. N. Okamura, C. Garau, D.M. Duangdao, S.D. Clark, K. Jüngling, H.C. Pape, and R.K. Reinscheid Neuropeptide S enhances memory during the consolidation phase and interacts with noradrenergic systems in the brain Neuropsychopharmacology 36 2011 744 752
43. N. Okamura, S.A. Habay, J. Zeng, A.R. Chamberlin, and R.K. Reinscheid Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro oxazolo[3, 4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor J Pharmacol Exp Ther 325 2008 893 901
44. N. Okamura, R.K. Reinscheid, S. Ohgake, M. Iyo, and K. Hashimoto Neuropeptide S attenuates neuropathological, neurochemical and behavioral changes induced by the NMDA receptor antagonist MK-801 Neuropharmacology 58 2010 166 172
45. R. Pacheco, B.B. Pescador, B.P. Mendonça, S.F. Ramos, R. Guerrini, G. Calo', V.M. de Andrade, E.C. Gavioli, and C.R. Boeck Role of the ecto-nucleotidases in the cooperative effect of adenosine and neuropeptide-S on locomotor activity in mice Pharmacol Biochem Behav 99 4 2011 726 730
46. 3H]nitrobenzylthioinosine adenosine uptake site binding in the mouse brain after acute pentylenetetrazol-induced seizures J Neurosci Res 53 1998 433 442
47. C. Pañeda, S. Huitron-Resendiz, L.M. Frago, J.A. Chowen, R. Picetti, L. de Lecea, and A.J. Roberts Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice J Neurosci 29 2009 4155 4161
48. H.C. Pape, K. Jüngling, T. Seidenbecher, J. Lesting, and R.K. Reinscheid Neuropeptide S: a transmitter system in the brain regulating fear and anxiety Neuropharmacology 58 1 2010 29 34
49. M. Patel Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures Free Radic Biol Med 37 2004 1951 1962
50. N. Patsoukis, G. Zervoudakis, C.D. Georgiou, F. Angelatou, N.A. Matsokis, and N.T. Panagopoulos Thiol redox state and lipid and protein oxidation in the mouse striatum after pentylenetetrazol-induced epileptic seizure Epilepsia 46 2005 1205 1211
51. Y.L. Peng, J.N. Zhang, M. Chang, W. Li, R.W. Han, and R. Wang Effects of central neuropeptide S in the mouse formalin test Peptides 31 2010 1878 1883
52. L. Raiteri, E. Luccini, C. Romei, S. Salvadori, and G. Calò Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings Br J Pharmacol 157 2009 474 481
53. R.K. Reinscheid, Y.L. Xu, and O. Civelli Neuropeptide S: a new player in the modulation of arousal and anxiety Mol Interv 5 2005 42 46
54. A. Rizzi, R. Vergura, G. Marzola, C. Ruzza, R. Guerrini, S. Salvadori, D. Regoli, and G. Calo Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice Br J Pharmacol 154 2008 471 479
55. L. Rocha, R.F. Ackermann, and J. Engel Jr. Chronic and single administration of pentylenetetrazol modifies benzodiazepine receptor-binding: an autoradiographic study Epilepsy Res 24 1996 65 72
56. A.L. Roth, E. Marzola, A. Rizzi, M. Arduin, C. Trapella, C. Corti, R. Vergura, P. Martinelli, S. Salvadori, D. Regoli, M. Corsi, P. Cavanni, G. Caló, and R. Guerrini Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation J Biol Chem 281 2006 20809 20816
57. L.F. Santos, R.L. Freitas, S.M. Xavier, G.B. Saldanha, and R.M. Freitas Neuroprotective actions of vitamin C related to decreased lipid peroxidation and increased catalase activity in adult rats after pilocarpine-induced seizures Pharmacol Biochem Behav 89 2008 1 5
58. H. Sejima, M. Ito, K. Kishi, H. Tsuda, and H. Shiraishi Regional excitatory and inhibitory amino acid concentrations in pentylenetetrazol kindling and kindled rat brain Brain Dev 19 1997 171 175
59. W. Si, L. Aluisio, N. Okamura, S.D. Clark, I. Fraser, S.W. Sutton, P. Bonaventure, and R.K. Reinscheid Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex J Neurochem 115 2010 475 482
60. K.L. Smith, M. Patterson, W.S. Dhillo, S.R. Patel, N.M. Semjonous, J.V. Gardiner, M.A. Ghatei, and S.R. Bloom Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake Endocrinology 147 2006 3510 3518
61. K. Sudha, A.V. Rao, and A. Rao Oxidative stress and antioxidants in epilepsy Clin Chim Acta 303 2001 19 24
62. J. Tchekalarova, E. Sotiriou, V. Georgiev, G. Kostopoulos, and F. Angelatou Up-regulation of adenosine A1 receptor binding in pentylenetetrazol kindling in mice: effects of angiotensin IV Brain Res 1032 1-2 2005 94 103
63. R.R. Tice, E. Agurell, D. Anderson, B. Burlinson, A. Hartmann, Y. Kobayashi, Y. Miyamae, E Rojas, J.C. Ryu, and Y.F. Sasaki Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing Environ Mol Mutagen 35 2000 206 221
64. A.R. Tomé, D. Feng, and R.M. Freitas The effects of alpha-tocopherol on hippocampal oxidative stress prior to in pilocarpine-induced seizures Neurochem Res 35 2010 580 587
65. P. Uma Devi, K.K. Pillai, and D. Vohora Modulation of pentylenetetrazole-induced seizures and oxidative stress parameters by sodium valproate in the absence and presence of N-acetylcysteine Fundam Clin Pharmacol 20 2006 247 253
66. G. Vitale, M. Filaferro, V. Ruggieri, S. Pennella, C. Frigeri, A. Rizzi, R. Guerrini, and G. Calò Anxiolytic-like effect of neuropeptide S in the rat defensive burying Peptides 29 2008 2286 2291
67. S.M. Xavier, C.O. Barbosa, D.O. Barros, R.F. Silva, A.A. Oliveira, and R.M. Freitas Vitamin C antioxidant effects in hippocampus of adult Wistar rats after seizures and status epilepticus induced by pilocarpine Neurosci Lett 420 2007 76 79
68. Y.L. Xu, C.M. Gall, V.R. Jackson, O. Civelli, and R.K. Reinscheid Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain J Comp Neurol 500 2007 84 102
69. Y.L. Xu, R.K. Reinscheid, S. Huitron-Resendiz, S.D. Clark, Z. Wang, S.H. Lin, FA. Brucher, J. Zeng, N.K. Ly, S.J. Henriksen, L. de Lecea, and O. Civelli Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects Neuron 43 2004 487 497
70. A.I. Zugno, F.M. Stefanello, E.B. Scherer, C. Mattos, C.D. Pederzolli, V.M. Andrade, C.M. Wannmacher, M. Wajner, C.S. Dutra-Filho, and A.T. Wyse Guanidinoacetate decreases antioxidant defenses and total protein sulfhydryl content in striatum of rats Neurochem Res 33 2008 1804 1810